Probing the fibrillation of Staphylococcal amyloids and their interactions with...
Probing the fibrillation of Staphylococcal amyloids and their interactions with Membranes at the Nanoscale
Phenol-soluble modulins α3 (PSMα3) are functional amyloids involved in the virulence of Staphylococcus aureus, a multi-drug resistant pathogen under the surveillance of the European Union (EU). The project PSMNano aims at unveilin...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
NanoStaph
Force nanoscopy of staphylococcal biofilms
2M€
Cerrado
PID2021-123682OB-I00
NANOSISTEMAS LIPIDIDICOS PARA APLICACIONES BIOMEDICAS.
157K€
Cerrado
FuncAmyloid
Structure, Function and Regulation of Antimicrobial and Viru...
2M€
Cerrado
CTQ2012-32236
BIONANOPARTICULAS MAGNETICAS-FLUORESCENTES DE METABOLISMO LE...
87K€
Cerrado
EXO-CHIP
Nanofluidics for label-free detection of exosomes and protei...
211K€
Cerrado
RTI2018-098027-B-C21
NUEVOS NANOVEHICULOS PARA TERANOSTICA DE ENFERMEDADES CEREBR...
151K€
Cerrado
Información proyecto PSMNano
Duración del proyecto: 24 meses
Fecha Inicio: 2022-06-03
Fecha Fin: 2024-06-30
Descripción del proyecto
Phenol-soluble modulins α3 (PSMα3) are functional amyloids involved in the virulence of Staphylococcus aureus, a multi-drug resistant pathogen under the surveillance of the European Union (EU). The project PSMNano aims at unveiling the molecular mechanisms driving PSMα3 interactions with cell membranes, which lead to their cytotoxic and proinflammatory activities, with a focus on the impact of amyloid fibrillation. So far poorly known, dissecting those mechanisms is yet critical to efficiently target PSMα3 activities, in turn S. aureus pathogenicity, and avoid the pandemics foreseen by the EU in the coming decades. Thanks to atomic force microscopy coupled to complementary multiscale biophysical tools, PSMNano will provide high spatiotemporal resolution multiparametric imaging of those interactions, while quantifying their affinity and energetic landscape, on both mimetic models and living cells. Remarkably, single-molecule experiments and cell budding will help decipher the forces driving the FPR2 receptor-dependent role of PSMα3. The expertise of the fellow Dr. Mathelié-Guinlet in surface chemistry and nanobiophysics related to bacterial virulence, the complementary knowledge she will acquire from the supervisor Pr. Molinari on membrane models design and spectroscopic investigations of amyloids, and the cutting-edge technical platforms of the host institution, CBMN (University of Bordeaux, France) will be instrumental for the success of this interdisciplinary project. The fundamental insights brought by the understanding of the role of PSMs-cell membrane interactions in S. aureus pathogenesis could set the stage for the design of novel therapeutics, e.g. inhibitors of PSMα3 activity. PSMNano could also open up avenues for standardized protocols to characterize amyloid-membrane interactions, involved in degenerative diseases. With valuable short- and long-term outcomes, this project will undoubtedly strengthen the competitiveness of the EU health program.